Equities

Global Pharmatech Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
GBLP:PKC

Global Pharmatech Inc

Actions
  • Price (USD)0.05
  • Today's Change0.00 / 0.00%
  • Shares traded2.12k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Jan 09 2026 20:23 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Global Pharmatech Inc is a company primarily engaged in the research, production and development of herbal medicine, bio-medicine, chemical medicine, traditional Chinese medicine (TCM) and dietary supplements. The Company’s main patented products include JUTAI SOFT CAPSULE, QINGXUAN ANTI-HYPERTENSION TABLET, YANREQING TABLET. The Company is also engaged in the manufacture and sales of other proprietary drugs, generics and dietary supplements used to treat symptoms ranging from headaches, coughing and dry mouth to infections and numbness of limbs. The Company also engages in the provision of biotechnology services, including research and development, testing, manufacturing drugs in liquid and solid dose forms, sales and marketing. The Company conducts its business in the domestic and overseas markets.

  • Revenue in USD (TTM)3.18m
  • Net income in USD-2.24m
  • Incorporated2001
  • Employees217.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Nexgel Inc11.67m-2.88m10.59m19.00--2.04--0.9075-0.3796-0.37961.530.63691.053.7913.46613,947.40-25.14-39.08-36.83-49.7938.3019.60-23.91-105.401.08-51.360.1439--112.4764.69-3.93------
Akari Therapeutics PLC (ADR)0.00-15.77m10.67m8.00---------0.600-0.6000.00--0.00----0.00-65.57-112.46-136.47-257.78-----------27.770.0854-------97.75------
Cellectar Biosciences Inc0.00-18.85m13.95m11.00--1.40-----10.78-10.780.002.940.00----0.00-72.62-104.57-141.24-133.43------------0.00-------4.23--33.54--
Lexaria Bioscience Corp522.00k-10.79m15.49m7.00--2.82--29.68-0.5743-0.57430.02720.2210.0659--2.9774,571.43-136.35-102.60-145.39-105.78100.0087.95-2,069.41-1,579.38---285.300.00--52.0517.53-105.37--48.50--
Hoth Therapeutics Inc0.00-12.16m15.82m2.00--1.87-----1.06-1.060.000.54420.00----0.00-138.61-129.47-154.67-144.30-----------493.480.00-------4.37------
CASI Pharmaceuticals Inc26.85m-49.38m17.47m233.00------0.6506-2.98-2.981.62-1.850.60961.604.22115,218.90-107.02-36.27-277.91-51.9053.6857.36-175.56-124.010.236-13.27-----15.7747.19-45.62---55.67--
Nutraproducts Inc0.00-821.94k20.12m0.00--3.36-----1.31-1.310.000.29730.00-------513.70-1,177.23-740.45-------------385.170.00--------------
Global Pharmatech Inc.3.18m-2.24m20.76m217.00--0.1459--6.53-0.0964-0.09640.13670.34280.22921.593.5714,649.77-16.44---22.55--46.21---71.75--1.62-9.870.2223--32.43---142.03------
Natural Alternatives International Inc134.44m-11.88m21.56m293.00--0.3123--0.1604-1.99-1.9922.5211.170.8454.357.36458,839.60-7.470.4593-9.150.54798.5012.75-8.840.42961.01-2.560.14080.0014.121.78-88.10---4.46--
Aytu Biopharma Inc62.64m-24.56m22.86m82.00--1.61--0.365-3.40-3.395.631.320.52592.102.22763,902.40-20.62-26.47-45.22-47.3266.8460.56-39.21-52.541.030.0570.5958--1.8419.16-13.27------
Dare Bioscience Inc27.69k-17.46m24.29m21.00--8.29--877.27-1.92-1.920.00290.20520.0011--0.06241,318.57-71.56-91.64-241.96-243.93127.70---63,069.55-1,024.05---156.390.7177---99.65--86.56------
Medicus Pharma Ltd-100.00bn-100.00bn26.62m-----------------0.0434-----------361.95----------------1.13-------109.90------
TherapeuticsMD Inc2.80m73.00k27.32m1.00378.210.995359.389.770.00620.02610.24192.370.0715--0.80022,796,000.000.1867-42.650.2169-112.14----2.61-193.47---5,240.000.00--35.25-48.7269.97------
Kyntra Bio Inc8.30m-131.13m30.14m225.00------3.63-32.4953.342.05-4.210.0413-1.470.42136,880.00-64.00-39.47-260.98-61.33345.6990.21-1,548.18-199.023.60--0.5269---36.71-35.0752.60---45.94--
United-Guardian Inc10.06m1.96m30.32m24.0015.472.8714.693.010.42660.42662.192.300.79113.827.58419,180.4015.4126.9117.8531.1650.6054.1619.4826.976.16--0.0092.3411.91-2.1825.94-7.3530.65-8.64
Data as of Jan 09 2026. Currency figures normalised to Global Pharmatech Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.